Target intelligence / Profile preview

microRNA 512-2 (miR-512-2)

Target
miR-512-2
Molecular classification
microRNA, noncoding RNA, miRNA
01

Overview

microRNA 512-2 is a member of the miRNA family, functioning as a noncoding single-stranded RNA molecule typically 21–24 nucleotides in length. It is transcribed as a primary miRNA (pri-miRNA) and processed via the canonical miRNA pathway involving Drosha and Dicer RNases, Exportin-5, and Argonaute proteins. The mature miRNA is loaded into the RNA-induced silencing complex (RISC), where it binds to partially complementary sequences in the 3′ UTR of target mRNAs, generally using a 6-8 nucleotide seed region for target recognition. This results in translational repression or mRNA destabilization. miR-512-2, like other miRNAs, is involved in diverse cellular processes such as cell development, proliferation, differentiation, apoptosis, and disease, especially cancer. Individual miRNAs, including miR-512-2, can regulate hundreds of target genes and have broad regulatory effects within cells. Modulation of miRNAs is being explored therapeutically, but specificity and biological complexity remain significant challenges. No drugs targeting miR-512-2 are identified in current literature, nor are established biomarkers or companion diagnostics, but miRNAs as a class are under active investigation for diagnostic and therapeutic applications—especially in oncology. Safety concerns chiefly relate to unintended effects due to extensive multi-gene regulatory networks and potential disruption of normal cellular processes. If you need more detail about specific gene targets, validated disease associations, or experimental data for miR-512-2, more targeted literature or database queries (e.g., miRBase, PubMed, GeneCards) would be required.

Other names
hsa-miR-512-2MIRN512-2mir-512-2MIR512-2hsa-mir-512-2
02

Mechanism of action

microRNA-mRNA interaction (seed-dependent pairing resulting in target mRNA translation inhibition or degradation), RISC-mediated gene silencing

03

Biological functions

gene expression regulationpost-transcriptional silencingcell proliferationdifferentiationapoptosistumorigenesis
04

Disease associations

Cancerinfectionhepatitis-associated hepatocellular carcinomacomplex diseases
05

Safety considerations

Potential off-target effects due to pleiotropic gene regulationchallenges in delivery and specificity for therapeutic applicationsunintended effects due to extensive multi-gene regulatory networkspotential disruption of normal cellular processes

Beyond the preview

Go deeper on microRNA 512-2 (miR-512-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 512-2 (miR-512-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call